Clinical Trials Browser

Phase 1/2 × Endometrial Neoplasms × Plasma cell × Clear all

NCT02393248 2023-01-06

Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)

Phase 1/2 Terminated

201 enrolled 71 charts

BreastGastrointestinalGynecologicMyeloidPlasma cellThoracic

Breast Neoplasms, Lung Neoplasms, Multiple Myeloma, Myeloproliferative Disorders, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT02907073 2019-05-17

Positron Emission Tomography (PET) Imaging Studies With NIS Reporter

Phase 1/2 Terminated

8 enrolled 4 charts

GynecologicPlasma cell

Endometrial Neoplasms, Neoplasms, Plasma Cell